THIRD AMENDMENT TO THE LICENSE AGREEMENT OF SEPTEMBER 20, 2013Tenax Therapeutics, Inc. • February 20th, 2024 • Pharmaceutical preparations
This Third Amendment to the License Agreement of September 20, 2013 (hereinafter referred to as the “Amendment”) is made and executed as of this 19th day of February, 2024 (“Effective Date of Amendment”) by and between:
